Livmoniplimab | m-entrepreneurship.com

Product Name :
Livmoniplimab

Search keywords :
Livmoniplimab

drugId :
null

Target Vo:
Transforming growth factor beta activator LRRC32

Target Vo Short Name :
LRRC32

Moa_Name:
Transforming growth factor beta activator LRRC32 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Argenx Se

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT1 alpha Antibody
Phospho-CREB (Ser133) Antibody (YA209)
Phospho-AMPK alpha 2(Ser345) Antibody: Phospho-AMPK alpha 2(Ser345) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa, targeting to Phospho-AMPK alpha 2(S345). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts